This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Kinki University, Link Genomics, Inc.. Active years: 2017.
Company Filing History:
1 out of 55 
1 out of 3 Years Active: 2017
Title: The Innovative Contributions of Hidemi Hayashi
Introduction
Hidemi Hayashi is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for cancer treatment. Her work focuses on creating innovative solutions to combat various malignant tumors.
Latest Patents
Hidemi Hayashi holds a patent for an "Antibody against transporter and use thereof." This invention provides a prophylactic or therapeutic agent for various malignant tumors, including currently intractable solid tumors. The patent describes an antibody that binds to human LAT1/CD98, inducing antibody-dependent cellular cytotoxicity specifically against cancer cells as an active ingredient. This groundbreaking work has the potential to improve treatment options for patients suffering from cancer.
Career Highlights
Throughout her career, Hayashi has worked with prominent organizations, including Link Genomics, Inc. and Kinki University. Her experience in these institutions has allowed her to collaborate with other experts in the field and contribute to significant advancements in cancer research.
Collaborations
Some of her notable coworkers include Dai Ogura and Takayuki Shindou. Their collaborative efforts have further enhanced the impact of her research and innovations in the biotechnology sector.
Conclusion
Hidemi Hayashi's contributions to cancer treatment through her innovative patent and collaborations with esteemed colleagues highlight her importance in the field of biotechnology. Her work continues to pave the way for new therapeutic strategies against malignant tumors.